Dr. Lal PathLabs Limited (BOM:539524)
India · Delayed Price · Currency is INR 1,399.70
-34.80 (-2.43%)
At close: Feb 13, 2026
Dr. Lal PathLabs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 26,628 | 24,614 | 22,266 | 20,169 | 20,874 | 15,813 |
Revenue Growth (YoY) | 10.75% | 10.54% | 10.40% | -3.38% | 32.01% | 18.86% |
Cost of Revenue | 11,050 | 10,373 | 9,476 | 8,920 | 9,198 | 7,047 |
Gross Profit | 15,578 | 14,241 | 12,790 | 11,249 | 11,676 | 8,765 |
Selling, General & Admin | 4,803 | 4,501 | 4,135 | 3,577 | 3,474 | 2,498 |
Other Operating Expenses | 3,060 | 2,717 | 2,528 | 2,769 | 2,569 | 1,895 |
Operating Expenses | 9,410 | 8,648 | 8,109 | 7,848 | 7,129 | 5,167 |
Operating Income | 6,168 | 5,593 | 4,681 | 3,402 | 4,547 | 3,598 |
Interest Expense | -217.05 | -223.05 | -293.59 | -375.3 | -301.71 | -159.95 |
Interest & Investment Income | 664.58 | 664.58 | 554.3 | 331.78 | 472.61 | 438.75 |
Other Non Operating Income (Expenses) | 119.35 | 22.35 | 1.24 | 1.02 | 1.27 | 16.52 |
EBT Excluding Unusual Items | 6,735 | 6,057 | 4,943 | 3,359 | 4,719 | 3,893 |
Gain (Loss) on Sale of Investments | 209.3 | 209.3 | 103.97 | 64.21 | 31.62 | 47.29 |
Gain (Loss) on Sale of Assets | -21.51 | -21.51 | -2.18 | 8.07 | -6 | -1.74 |
Other Unusual Items | -297.65 | 3.35 | 9.29 | 6.96 | 4.95 | 5.42 |
Pretax Income | 6,625 | 6,248 | 5,055 | 3,438 | 4,750 | 3,944 |
Income Tax Expense | 1,293 | 1,325 | 1,432 | 1,028 | 1,247 | 979.3 |
Earnings From Continuing Operations | 5,332 | 4,923 | 3,623 | 2,411 | 3,503 | 2,965 |
Minority Interest in Earnings | -48.14 | -51.14 | -45.58 | -22.29 | -54.58 | -48.58 |
Net Income | 5,283 | 4,871 | 3,577 | 2,388 | 3,448 | 2,916 |
Net Income to Common | 5,283 | 4,871 | 3,577 | 2,388 | 3,448 | 2,916 |
Net Income Growth | 26.75% | 36.17% | 49.78% | -30.73% | 18.25% | 29.07% |
Shares Outstanding (Basic) | 167 | 167 | 166 | 166 | 165 | 165 |
Shares Outstanding (Diluted) | 167 | 167 | 166 | 166 | 166 | 165 |
Shares Change (YoY) | 0.21% | 0.22% | 0.14% | 0.21% | 0.24% | 0.23% |
EPS (Basic) | 31.66 | 29.24 | 21.52 | 14.41 | 20.85 | 17.66 |
EPS (Diluted) | 31.63 | 29.20 | 21.49 | 14.37 | 20.79 | 17.62 |
EPS Growth | 26.49% | 35.88% | 49.55% | -30.86% | 17.93% | 28.79% |
Free Cash Flow | - | 5,246 | 4,842 | 4,195 | 3,526 | 3,626 |
Free Cash Flow Per Share | - | 31.44 | 29.08 | 25.24 | 21.25 | 21.91 |
Dividend Per Share | 13.000 | 12.000 | 12.000 | 6.000 | 6.000 | 10.000 |
Dividend Growth | 8.33% | - | 100.00% | - | -40.00% | 66.67% |
Gross Margin | 58.50% | 57.86% | 57.44% | 55.77% | 55.94% | 55.43% |
Operating Margin | 23.16% | 22.72% | 21.02% | 16.86% | 21.78% | 22.75% |
Profit Margin | 19.84% | 19.79% | 16.07% | 11.84% | 16.52% | 18.44% |
Free Cash Flow Margin | - | 21.31% | 21.74% | 20.80% | 16.89% | 22.93% |
EBITDA | 7,151 | 6,579 | 5,673 | 4,412 | 5,188 | 3,989 |
EBITDA Margin | 26.85% | 26.73% | 25.48% | 21.88% | 24.86% | 25.22% |
D&A For EBITDA | 982.77 | 986.35 | 991.13 | 1,011 | 641.4 | 390.94 |
EBIT | 6,168 | 5,593 | 4,681 | 3,402 | 4,547 | 3,598 |
EBIT Margin | 23.16% | 22.72% | 21.02% | 16.86% | 21.78% | 22.75% |
Effective Tax Rate | 19.52% | 21.21% | 28.32% | 29.88% | 26.25% | 24.83% |
Revenue as Reported | 27,659 | 25,548 | 22,958 | 20,586 | 21,400 | 16,326 |
Advertising Expenses | - | 778.41 | 733.49 | 507.8 | 367.64 | 307.21 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.